Prospera Financial Services Inc Editas Medicine, Inc. Transaction History

Prospera Financial Services Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$9.99 - $21.35 $4,245 - $9,073	-425 Reduced 62.04%	260 $3,000
Q1 2022 May 04, 2022	BUY	$14.08 - $27.63 $9,644 - $18,926	685 New	685 $13,000
Q1 2021 May 06, 2021	SELL	$39.71 - $90.58 $172,103 - $392,573	-4,334 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$27.07 - $84.35 $117,321 - $365,572	4,334 New	4,334 $304,000

250

57.1M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $83.9M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.